Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.
about
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutininsInfluenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tractsCleavage of hemagglutinin-bearing lentiviral pseudotypes and their use in the study of influenza virus persistenceInfluenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.Pseudotype-based neutralization assays for influenza: a systematic analysis.Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus InfectivityCross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2.Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian virusesComparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferretDiscordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals.An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza virusesTMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCREstablishment of MDCK Stable Cell Lines Expressing TMPRSS2 and MSPL and Their Applications in Propagating Influenza Vaccine Viruses in Absence of Exogenous Trypsin.Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum.Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing AntibodiesDetermination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodiesThe human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes.Mucosal antibody responses are directed by viral burden in children with acute influenza infection.Exploration of binary virus-host interactions using an infectious protein complementation assayDetection of antibodies against H5 and H7 strains in birds: evaluation of influenza pseudovirus particle neutralization tests.Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.Human airway trypsin-like protease, a serine protease involved in respiratory diseases.High-throughput screening of viral entry inhibitors using pseudotyped virus.Hepatitis B virus surface antigen assembly function persists when entire transmembrane domains 1 and 3 are replaced by a heterologous transmembrane sequence.A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus.The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus.A report on the association of influenza B virus with respiratory tract infection of hospitalized children in Saudi Arabia.A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus.Advances in diagnosis of respiratory virus infections.H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice.Current status on the development of pseudoviruses for enveloped viruses.
P2860
Q27671165-52074716-90FB-4583-9FBA-85EE38960B80Q28730201-6794F19C-FEA3-4537-A523-B97DCACD1C95Q30366190-3EB1D499-E3E1-4DD3-817F-8ED5F46405DEQ30369380-3573457C-6CA0-4000-AF64-19E97512ADFAQ30374662-F6D75677-BB94-4CE2-96E5-F6BB614F7B7DQ30377531-A2993DEE-DF39-49D7-8442-9987C874CE27Q30377845-4EB79867-A1AD-4845-9A33-E1AE95EE476BQ30404095-BEADA837-24F9-48D7-B8A7-A0EEFBA9DEB1Q30406634-74FEE69C-9432-4E22-9BFE-06D007CA688FQ30423166-F833AD4B-3E5F-40DF-A711-32768B170EE6Q30429267-A93B0282-B267-4CF5-9968-871BCC92E8B3Q33547457-FE878382-5382-4CF3-B77C-C1274ED29407Q33809686-BEB7F89B-31D5-4643-A777-5A836A0D1F14Q34046083-D59402C9-FCAF-40AF-A4D6-11D61C577C7EQ34120814-B8C6DA78-B77D-40F7-ADD3-6A723B30BAE0Q34194336-958E82CF-C941-4110-81D9-5DD72325E4FBQ34365035-E4C5C387-492D-455A-9782-754B30EEA357Q34598349-068CDFFD-97BE-4339-A861-8468D6BD7952Q35412451-C4D418AE-FE3D-4925-98F0-9FA54E29732DQ35530244-EFDF181C-8297-4358-8429-5D993C2E2B89Q35550576-3C8180D9-8F97-4A65-873E-77B1AB15731EQ35647772-207B16D3-842F-4426-AFDA-BE884022A21CQ35826733-439B0031-D88A-43E8-B51B-07826A9FE472Q35919479-C9403580-5CA0-49FB-9A87-7FA7D7579AB8Q36350940-1F64AFD2-F142-433E-8CA7-78671247A22BQ36734159-669F4ECC-ACC5-4CD8-94A9-908D3E4C6CC0Q37179280-79890638-A534-4DDC-8087-FB25C2DCD778Q37214687-A987364A-6745-4886-B58F-2021C567F591Q37491678-9BEBE944-F0BB-4CD4-A09D-CCE122AD310EQ37866816-1798E7B8-12F6-44FE-B0F7-5F3A133DD824Q39149977-937DDB31-7C77-4798-ACE0-92A939D0B1D4Q39470519-3421DAA7-4E20-434D-82E7-9C6FACA0FE42Q39617158-49A7F8C8-807A-49DA-897F-C3315A59B634Q40091174-F3FE0515-14E4-419F-AE23-AF1225B4A72DQ40248004-B464FF29-608F-4F19-B477-1FEB0112B1B8Q41880853-CFD45CF7-7DEA-466E-B3CD-B10EE602834CQ42212662-95C079A6-9ACB-432D-99FF-526B05032B61Q42407466-C0644B2F-493F-406A-9544-957E3BD6EEEEQ45358893-58A0E2BB-8F69-4BDD-AED7-1A0CC6743DEAQ47568014-CABA74FE-E574-475F-9E4B-13CD8F57BC5D
P2860
Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Establishment of retroviral ps ...... on of neutralizing antibodies.
@en
Establishment of retroviral ps ...... on of neutralizing antibodies.
@nl
type
label
Establishment of retroviral ps ...... on of neutralizing antibodies.
@en
Establishment of retroviral ps ...... on of neutralizing antibodies.
@nl
prefLabel
Establishment of retroviral ps ...... on of neutralizing antibodies.
@en
Establishment of retroviral ps ...... on of neutralizing antibodies.
@nl
P2093
P1476
Establishment of retroviral ps ...... on of neutralizing antibodies.
@en
P2093
Carol D Weiss
Eboneé N Butler
J Terrig Thomas
Kathy Hancock
Malcolm Moos
Russell Vassell
Vic Veguilla
Zhiping Ye
P304
P356
10.1016/J.JVIROMET.2008.07.015
P577
2008-09-04T00:00:00Z